Region: Central America
Category: Healthcare

Central America Healthcare

(27 reports matching your criteria)
  • Costa Rica Pharmaceuticals & Healthcare Q3 2020

    ... adaptation by the health system,including resources diverted towards controlling the emergency outbreak, will continue to be carried out. Based on market growthfundamentals, Costa Rica's pharmaceuticals and healthcare spending will post robust growth over the next ... Read More

  • Panama Pharmaceuticals & Healthcare Q3 2020

    ... as resources are diverted towardsstrengthening the country's response to the coronavirus outbreak. The impact of Covid-19 on overall pharmaceutical spending willbe less evident, as most additional spending is directed towards healthcare capacity and consumables. Over ... Read More

  • Guatemala Pharmaceuticals & Healthcare Q2 2020

    ... aimed at controlling drug prices and ensuring broader access totreatment will remain a policy priority. Corruption and broader political risks, as well as an underdeveloped health system, willcontinue to weigh on the market’s growth potential. Read More

  • Honduras Pharmaceuticals & Healthcare Q2 2020

    ... long term, the country’s small population and low per capitaspending on medicines will present few opportunities for innovative drugmakers. Furthermore, with high levels of corruption and aninadequate regulatory environment, we continue to view Honduras as ... Read More

  • El Salvador Pharmaceuticals & Healthcare Q2 2020

    ... and to attract foreign investment. At the sametime, coordinated renovation campaigns at health centres across the country have seen a gradual improvement to the standard ofcare, even though questions still remain over the regulatory framework, ... Read More

  • Nicaragua Pharmaceuticals & Healthcare Q2 2020

    ... positive growth outlook for the country’s pharmaceutical and healthcaremarkets. However, despite potential long-term opportunities arising from a growing chronic disease burden, as one of the smallestmarkets in the region with low purchasing power, Nicaragua will ... Read More

  • Herbal/Traditional Products in Costa Rica

    ... of supporting multiple types of health conditions, including digestive support, coughs and cold, and weight management. The penetration of these proposals continues to gain momentum across a broader range of healthcare specialists and modern grocery ... Read More

  • Herbal/Traditional Products in Guatemala

    ... them feel confident that they are safe. In order to compete with herbal/traditional products and give consumers what they are looking for, many OTC offerings have added natural ingredients. An example of this is Sal ... Read More

  • Consumer Health in Panama

    ... and dietary supplements. Despite continued macroeconomic growth, income inequality is significant and healthcare coverage varies considerably between poor rural communities and the urban middle class. As such, there remains scope for further sales growth from ... Read More

  • Consumer Health in El Salvador

    ... El Salvador report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. ... Read More

  • Consumer Health in Honduras

    ... offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. Forecasts to 2023 ... Read More

  • Medical Tourism Market Size, Share & Trends Analysis Report By Country (Costa Rica, Mexico, India, Thailand, Malaysia, and Singapore), Competitive Landscape, and Segment Forecasts, 2018 - 2025

    ... expected to reach USD 131.35 billion by 2025, according to a new report by Grand View Research, Inc., expanding at a CAGR of 20.24% during the forecast period. Growing geriatric population coupled with improving accessibility ... Read More

  • Guatemala Pharmaceuticals & Healthcare Q2 2018

    ... that demand for medical treatment remains on the rise. Morebroadly, the relatively large and growing population will drive commercial opportunities for drugmakers and healthcare suppliers.However, low per capita spending on medicine and a poor operating ... Read More

  • Guatemala Pharmaceuticals & Healthcare Report Q4 2017

    ... to weigh on business sentiment in the near term. In fact, corruption allegations against administration officials will continue to undermine government efforts to boost growth through infrastructure development projects, translating into limited bidders for public ... Read More

  • El Salvador Pharmaceuticals and Healthcare Report Q4 2017

    ... of Health's efforts to solicit outside assistance to bolster healthcareprovision in all quarters of the country. Despite improvements in the regulatory environment since TheMedicines Law of El Salvador was approved in 2012, steady multinational FDI ... Read More

  • Costa Rica Pharmaceuticals and Healthcare Report Q4 2017

    ... medical tourism destination and expandinghealthcare infrastructure that will need to cater to its gradually ageing population. However, the smallmarket size will continue to hamper its growth potential as well as its relative attractiveness. Headline Expenditure ... Read More

  • Nicaragua Pharmaceuticals and Healthcare Report Q4 2017

    ... of the overallmarket is among the smallest in Central America and is limited by a largely low-income population with astrong preference for traditional medicines. Furthermore, weak drug regulatory framework and poorhealthcare infrastructure will dampen multinational ... Read More

  • Honduras Pharmaceuticals and Healthcare Report Q4 2017

    ... weak regulatory environment and low levels of affordability will hold back innovativemedicine sales. We expect low-cost generic medicines will continue to dominate the market as thegovernment looked to improve healthcare coverage within a limited budget. ... Read More

  • Panama Pharmaceuticals and Healthcare Report Q4 2017

    ... by regionalstandards, Panama will continue to create commercial opportunities for foreign drugmakers given risingdemand for chronic disease treatment and the limited local drug manufacturing capacity. However, genericmedicine usage will remain relatively high despite high spending ... Read More

  • CCSS/APHNN – Torre Esperanza Children Hospital Development – Costa Rica Project Profile

    ... project overview and location. The profile also details project ownership and funding, gives a full project description, as well as information on contracts, tendering and key project contacts. The "CCSS/APHNN – Torre Esperanza Children Hospital ... Read More

  • MS – Hospital Panama Norte – Panama Project Profile

    ... also details project ownership and funding, gives a full project description, as well as information on contracts, tendering and key project contacts. The "MS – Hospital Panama Norte – Panama Project Profile" is part of ... Read More

  • HDN – Children Hospital – Panama City Project Profile

    ... also details project ownership and funding, gives a full project description, as well as information on contracts, tendering and key project contacts. The "HDN – Children Hospital – Panama City Project Profile" is part of ... Read More

  • Guatemala Pharmaceuticals and Healthcare Report Q2 2016

    ... However, in spite of this, the country will continue to attract investment as a regionalpharmaceutical production hub. Since the end of the 36-year civil war in 1996, Guatemala's politicalstability has been progressing and tax incentives ... Read More

  • Panama Pharmaceuticals and Healthcare Report Q2 2016

    ... the country over the long term.The planned operational enhancements will also increase medicine consumption and demand forhealthcare supplies, thus improving the country's appeal to foreign investors. The strong trade environmentdue to the Colon Free Trade ... Read More

  • Nicaragua Pharmaceuticals and Healthcare Report Q2 2016

    ... a small andunregulated drug market and the socio-cultural preference for traditional medicines will present limitedopportunities for innovative drugmakers.Headline Expenditure ProjectionsPharmaceuticals: NIO10.93bn (USDb401mn) in 2015 to NIO11.42bn (USD399mn) in 2016; +4.3% inlocal currency terms, and -0.7% ... Read More

< prev 1

Research Assistance

Central America Healthcare Reports

Join Alert Me Now!

Sign Up

Find out more on our blog